CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients - Concepedia

Concepedia

Publication | Closed Access

CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients

155

Citations

27

References

2019

Year

Paul J. Pockros, Michael Fuchs, B. Freilich, Eugene R. Schiff, Anita Kohli, Eric Lawitz, Paul Hellstern, Janet Owens‐Grillo, Courtney Van Biene, Reshma Shringarpure,

Liver International

Abstract

The CONTROL study showed that OCA-induced increases in LDLc in patients with NASH were mitigated with atorvastatin. The combination of OCA and atorvastatin was generally safe and well tolerated (NCT02633956).

References

	Year	Citations

Page 1